0001477932-22-004373.txt : 20220614 0001477932-22-004373.hdr.sgml : 20220614 20220614172506 ACCESSION NUMBER: 0001477932-22-004373 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 18 CONFORMED PERIOD OF REPORT: 20220606 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220614 DATE AS OF CHANGE: 20220614 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Healing Co Inc. CENTRAL INDEX KEY: 0001441082 STANDARD INDUSTRIAL CLASSIFICATION: METAL MINING [1000] IRS NUMBER: 262862618 STATE OF INCORPORATION: NV FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-152805 FILM NUMBER: 221015883 BUSINESS ADDRESS: STREET 1: 11TH FLOOR, TEN GRAND STREET, CITY: BROOKLYN STATE: NY ZIP: 11249 BUSINESS PHONE: 866-241-0670 MAIL ADDRESS: STREET 1: 11TH FLOOR, TEN GRAND STREET, CITY: BROOKLYN STATE: NY ZIP: 11249 FORMER COMPANY: FORMER CONFORMED NAME: Lake Forest Minerals Inc. DATE OF NAME CHANGE: 20080725 8-K 1 thcc_8k.htm FORM 8-K thcc_8k.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported) June 14, 2022 (June 6, 2022)

 

THE HEALING COMPANY INC.

(Exact name of registrant as specified in its charter)

 

Nevada

 

333-152805

 

26-2862618

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

11th Floor, Ten Grand Street, Brooklyn, New York

 

11249

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code +1 866-241-0670

 

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13(c))

 

Title of each class

 

 

Trading

Symbol(s)

 

 

Name of each exchange

 on which registered

Not Applicable

 

 

 

 

 

 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

Item 5.02, Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers

 

Departure of Principal Officers:

 

On June 6, 2022, The Healing Company Inc. (the “Company”) received the resignation of Mr. Lee Larson Elmore as Secretary, Treasurer and Chief Financial Officer of the Company. Mr. Elmore did not resign due to any dispute or disagreement with the Company or its practices.

 

On June 6, 2022, the Company received a consent to act as Secretary, Treasurer and Chief Financial Officer of the Company from Amit Kapur. Further, concurrently, the board of directors of the Company (the “Board”) approved Mr. Kapur’s offer letter dated June 2, 2022 (the “Offer Letter”) and appointed Mr. Kapur Secretary, Treasurer and Chief Financial Officer of the Company.

 

Under the terms of the Offer Letter to commence June 6, 2022 (the “Start Date”), Mr. Kapur will be paid an annual base salary of $300,000 subject to review annually for increase, but not decrease, payable semi-monthly in accordance with the standard payroll practices of the Company and subject to all withholdings and deductions as required by law. Further, Mr. Kapur shall have the right to receive an annual bonus as determined by the Board and based on Company results and the achievement of applicable performance goals established by the Board. Additionally, Mr. Kapur shall receive an option to purchase One Million Two Hundred Fifty Thousand (1,250,000) shares of Company common stock in accordance with the terms of the Company’s 2022 Omnibus Equity Incentive Plan and its standard option agreement, once approved by the Board (the “Option”). The Option shall be exercisable at the fair market value of the common stock on the employment Start Date and shall have a term of ten (10) years. The shares subject to the Option shall vest ratably over a four (4) year period commencing on the employment Start Date (“Vesting Start Date”) as follows: 25% upon the 12-month anniversary of the Vesting Start Date, and at a rate of 1/48 of the number of shares initially subject to the Option for each full calendar month thereafter (such that 100% of the Shares shall be vested as of the fourth anniversary of the Vesting Start Date).

 

The employment offer and acceptance is for no fixed term and can be terminated by either party with or without cause, and with or without notice and for any reason or no particular reason.

 

Mr. Kapur will be eligible to participate in the employee benefit plans and programs generally available to the Company’s executives and he will be subject to non-competition and non-solicitation provisions. If Mr. Kapur’s employment with the Company is involuntarily terminated for reasons other than Cause (as defined in the Offer Letter) or a breach by him of the terms and conditions of the Offer Letter (including, but not limited to, a breach of any of the representations contained therein), he shall be entitled to continue to receive his base salary through the three-month anniversary of the effective date of termination if the termination occurs prior to the one-year anniversary of the Start Date, and through the six-month anniversary of the effective date of termination if the termination occurs after the one-year anniversary of the Start Date.

 

The foregoing summary of the material terms of the agreement with Mr. Kapur described above does not purport to be complete and is qualified in its entirety by reference to the full text of the Offer of Employment appended as an exhibit to this filing.

 

 
2

 

 

Amit Kapur, Secretary, Treasurer and Chief Financial Officer.

 

Mr. Kapur has more than 20 years of chief financial leadership positions with an array of consumer goods, venture capital, private equity and consulting experience. He is a detailed-oriented, driven, executive with an extremely strong track record of leadership, business development, revenue generation, communication, project management, financial control, operations, IT, capital markets, and other corporate activities. He possesses exceptional analytical skills, with the ability to examine and understand business needs and deliver comprehensive reports for external groups while exceeding rigorous expectations. His academic credentials include a fundamental background in valuation, analytics, and research. His skills include the evaluation of new ventures and investment opportunities. He has a large network of associates which includes CEO/CFO/COOs, high net worth investors, entrepreneurs, and senior management in various industries.

 

Mr. Kapur is joining the Company after spending more than three years (from February 2019) with The Anthos Group, a company with a market cap of $100 million, where he served as Chief Financial Officer and Chief Operating Officer of Farms. During his term at The Anthos Group, he undertook various duties for that company including overseeing and developing policies whereby the company was able to reduce its G&A expenses by 40% and reduce capital expenditures while growing revenues. He also participated in the closing of financings for that company and the structuring and closing of various joint ventures.

 

In 2004, Mr. Kapur founded a real estate private equity fund and he still sits as Chairman of the Board of that company.

 

Mr. Kapur has had varied positions throughout his career, as a senior auditor for a large accounting firm prior to 2004 and from June 2017 to March 2019, he was a member and executive at Toptal, LLC, a company providing an exclusive network of the top freelance software developers, designers, finance experts product managers and project managers where he was assigned various projects over a broad spectrum of companies.

 

Educated at Northwestern͛ Kellogg School of Management, he has a Master’s of Business Administration with a focus on finance, entrepreneurship and marketing and also holds degrees from the University of Illinois at Chicago (UIC) (Bachelor of Science, Accounting) and the University of Delhi (Bachelor of Science, Business Commerce, Honors).

 

Mr Kapur also sits on the Board of Directors of Superfyt and is a member of CFOrward and a contributor to Think Deal Training.He is a Board member of Found Chicago Dog Training and Rescue Home, the Vice Chairman of Dreams for Kids, the Founder of Kapur Christmas Drive which annually feeds and clothes hundreds of homeless across Chicago and a Mentor of the Boys and Girls Club.

 

Other than the arrangements reported in this Item 5.02, there are no arrangements or understandings between the above officer and any other persons pursuant to which he was selected as anofficer. There are also no family relationships between Mr. Kapur and any other officers or directors of the company and none have any direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.

 

Description of Exhibit

10.1

 

Offer Letter to Amit Kapur dated June 2, 2022

104

 

Cover Page Interactive Data File (formatted as Inline XBRL)

 

 
3

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

THE HEALING COMPANY INC.

 

/s/ Simon Belsham

Simon Belsham

Chief Executive Officer

 

Date: June 14, 2022

 

 
4

 

 EX-10.1 2 thcc_101.htm OFFER LETTER thcc_101.htm

 

EXHIBIT 10.1

 

 

Amit Kapur

1300 N. Cleveland Ave

Chicago, IL 60610

 

June 2, 2022

 

Dear MR. Kapur,

 

Offer and Position

 

We are very pleased to extend an offer of employment to you for the position of Chief Financial Officer, Secretary and Treasurer (“CFO”) of The Healing Company, Inc., a Nevada corporation (the “Company”). This offer of employment (“Offer Letter”) is conditioned on your satisfactory completion of certain requirements, as more fully explained in this letter. Your employment is subject to the terms and conditions set forth in this letter.

 

Duties

 

In your capacity as CFO, you will perform duties and responsibilities that are commensurate with your position and such other duties as may be assigned to you from time to time. You will report directly to the Chief Executive Officer (“CEO”) of the Company, currently Simon Belsham. You agree to devote your full business time, attention, and best efforts to the performance of your duties and to the furtherance of the Company’s interests. Notwithstanding the foregoing, nothing in this letter shall preclude you from devoting reasonable periods of time to charitable and community activities, managing personal investment assets and, subject to Board approval which will not be unreasonably withheld, serving on boards of other companies (public or private) not in competition with the Company, provided that none of these activities interferes with the performance of your duties hereunder or creates a conflict of interest.

 

Location

 

Your principal place of employment shall initially be remote, subject to business travel as needed to properly fulfill your employment duties and responsibilities.

 

Start Date

 

Subject to satisfaction of all of the conditions described in this letter, your anticipated start date is June 6, 2022 (“Start Date”).

 

Base Salary

 

In consideration of your services, you will be paid an initial base salary of $300,000.00 per year (“Base Salary”), subject to review annually for increase, but not decrease, payable semi-monthly in accordance with the standard payroll practices of the Company and subject to all withholdings and deductions as required by law.

 

11th Floor, Ten Grand Street, Brooklyn, NY 11249

www.healingcompany.com

 

 
1

 

 

 

Annual Bonus

 

During your employment, you may be eligible to receive a discretionary annual bonus, payable at such times and in such amounts, as determined by the Board. Actual payments will be determined based on a combination of Company results and individual performance against the applicable performance goals established by the Board. Any earned annual bonus with respect to a particular fiscal year will be paid within 2 1/2 months following the end of the year. For any partial year of employment in which a bonus is earned, you will receive a pro-rated annual bonus based on the number of days you are employed during the year.

 

You must remain continuously employed through the bonus payment date to be eligible to receive an annual bonus payment for a particular fiscal year.

 

Equity Grants

 

At the next regularly scheduled meeting of the Compensation Committee following your Start Date, the Company will recommend to the Compensation Committee that it grant you an option (“Option”) to purchase One Million Two Hundred Fifty Thousand (1,250,000) shares of Common Stock in accordance with the terms of the Company’s stock incentive plan and its standard option agreement, which shall vest in accordance with the terms and conditions outlined in the plan and agreement, and otherwise as described in this Offer Letter. The Option shall be exercisable at the fair market value of the Common Stock on the employment Start Date and shall have a term of ten (10) years. The shares subject to the Option (“Shares”) shall vest ratably over the four (4) year period commencing on the employment Start Date (“Vesting Start Date”) as follows: 25% upon the 12-month anniversary of the Vesting Start Date, and at a rate of 1/48 of the number of shares initially subject to the Option for each full calendar month thereafter (such that 100% of the Shares shall be vested as of the fourth anniversary of the Vesting Start Date), provided that you are employed by the Company on each such vesting date, subject to acceleration as provided in the Company’s equity incentive plan or as otherwise provided in the option agreement.

 

Benefits and Perquisites

 

You will be eligible to participate in the employee benefit plans and programs generally available to the Company’s executives, including group medical, dental, vision and life insurance and disability benefits, subject to the terms and conditions of such plans and programs. You will be entitled to paid vacation in accordance with the Company’s policies in effect from time to time. You will also be entitled to the fringe benefits and perquisites that are made available to other similarly situated executives of the Company, each in accordance with and subject to the eligibility and other provisions of such plans and programs. The Company reserves the right to amend, modify or terminate any of its benefit plans or programs at any time and for any reason.

 

Withholding

 

All forms of compensation paid to you as an employee of the Company shall be less all applicable withholdings.

 

11th Floor, Ten Grand Street, Brooklyn, NY 11249

www.healingcompany.com

      

 
2

 

 

 

Stock Ownership Requirements

 

As a CFO of the Company, you will be required to comply with the Company’s stock ownership requirements applicable to employees, including executive officers.

 

Non-Competition and Other Restricted Activity.

 

(a) Non-Competition. During your employment with the Company, you will not, directly or indirectly, compete with the Company, anywhere in the world, whether as an owner, partner, investor, consultant, employee or otherwise. Further, during the twelve (12) month period immediately following the termination of your employment for any reason, you will not work for or provide services to, in any capacity, whether as an employee, independent contractor or otherwise, whether with or without compensation, to any material competitor. The foregoing shall not prevent: (i) passive ownership by you of no more than 2% of the equity securities of any publicly traded company; or (ii) you providing services to a division or subsidiary of a multi-division entity or holding company, so long as no division or subsidiary to which you provide services is a material competitor, and you do not otherwise engage in competition on behalf of the multi-division entity or any competing division or subsidiary thereof.

 

(b) Good Will. Any and all good will which you develop during your employment with any of the customers, prospective customers, subsidiaries, subcontractors or suppliers of the Company shall be the sole, exclusive and permanent property of the Company, and shall continue to be such after termination of your employment, howsoever caused.

 

(c) Non-Solicitation of Customers. During your employment with the Company and during the twelve (12) month period immediately following the termination of such employment for any reason, you will not, directly or indirectly, (i) solicit, encourage or induce any customer of the Company or its subsidiaries to terminate or diminish in any material respect its relationship with the Company; or (ii) seek to persuade or induce any such customer or prospective customer of the Company or its subsidiaries to conduct with anyone else any substantial business or activity which such customer or prospective customer conducts or could conduct with the Company or its subsidiaries; provided that the restrictions in (i) and (ii) shall apply (A) only with respect to those persons or entities who are or have been a customer of the Company or its subsidiaries at any time within the immediately preceding one-year period or whose business has been solicited on behalf of the Company or its subsidiaries by any of its officers, employees or agents within said one-year period, other than by form letter, blanket mailing or published advertisement, and (ii) only if you have performed work for such person or entity during your employment with the Company or have been introduced to, or otherwise had contact with, such person or entity as a result of your employment or other associations with the Company or has had access to Confidential Information which would assist in the solicitation of such person or entity. The foregoing restrictions shall not apply to general solicitation or advertising, including through media and trade publications.

 

11th Floor, Ten Grand Street, Brooklyn, NY 11249

www.healingcompany.com

       

 
3

 

 

 

 

(d) Non-Solicitation/Non-Hiring of Employees and Independent Contractors. During your employment with the Company and for the twelve (12) month period immediately following the termination of such employment for any reason, you will not, and will not assist anyone else to, (i) hire or solicit for hiring any employee of the Company or its subsidiaries or seek to persuade or induce any employee of the Company or its subsidiaries to discontinue employment with the Company or its subsidiaries, or (ii) hire or engage any independent contractor providing services to the Company or its subsidiaries, or solicit, encourage or induce any independent contractor providing services to the Company or its subsidiaries to terminate or materially diminish in any substantial respect its relationship with the Company or its subsidiaries. For the purposes of this section, an “employee” or “independent contractor” of the Company or its subsidiaries is any person or entity who is or was such at any time within the preceding six (6) month period. The foregoing restrictions shall not apply to general solicitation or advertising, including through media, trade publications and general job postings.

 

(e) Notice of New Address and Employment. During the twelve (12) month period immediately following the termination of your employment for any reason, you will use reasonable best efforts to provide the Company with pertinent information concerning each new job or other business activity in which you engage or plan to engage during such twelve (12) month period as the Company may reasonably request in order to determine your continued compliance with your obligations under this Offer Letter. You shall notify your new employer(s) of your obligations under this Offer Letter, and hereby consent to notification by the Company to such employer(s) concerning your obligations under this Offer Letter. The Company shall treat any such notice and information as confidential, and will not use or disclose the information contained therein except to enforce its rights hereunder.

 

(f) Acknowledgement of Reasonableness; Remedies. In signing this Offer Letter, you give the Company assurance that you have carefully read and considered all the terms and conditions hereof. You acknowledge without reservation that each of the restraints contained herein is necessary for the reasonable and proper protection of the good will, Confidential Information and other legitimate business interests of the Company and its subsidiaries, that each and every one of those restraints is reasonable in respect to subject matter, length of time and geographic area; and that these restraints will not prevent you from obtaining other suitable employment during the period in which you are bound by them. You will never assert, or permit to be asserted on your behalf, in any forum, any position contrary to the foregoing. Were you to breach any of the provisions of this section, the harm to the Company would be irreparable. Therefore, in the event of such a breach or threatened breach, the Company shall, in addition to any other remedies available to it, have the right to obtain preliminary and permanent injunctive relief against any such breach or threatened breach without having to post bond.

 

(g) Severability. In the event that any provision of this section shall be determined by any court of competent jurisdiction to be unenforceable by reason of its being extended over too great a time, too large a geographic area or too great a range of activities, such provision shall be deemed to be modified to permit its enforcement to the maximum extent permitted by law. The twelve (12) month periods set forth in this section shall be tolled, and shall not run, during any period of time in which you are in violation of the terms thereof, in order that the Company shall have the agreed-upon temporal protection recited herein.

 

11th Floor, Ten Grand Street, Brooklyn, NY 11249

www.healingcompany.com

       

 
4

 

 

 

(h) No Disparaging Comments. You agree that at no time during the term of your employment or after the conclusion thereof will you disparage the Company, its subsidiaries, or any agents, employees, consultants or members of the Boards of the foregoing (collectively, “Company Entities and Persons”). Following the date of termination of your employment, the Company will (a) not issue any press release or make any similar public statement concerning that disparages you and (b) issue a written directive to all of the then-current members of the Board and executive officers of the Company, instructing them that, while in such capacities, they should not, directly or indirectly, criticize or otherwise disparage or solicit or encourage others to criticize or otherwise disparage you; provided, that upon issuance of that directive, the Company will have satisfied all obligations to you under this section. For purposes of this Offer Letter, “disparage” includes, but is not limited to, comments or statements, whether written or verbal in any medium, that materially adversely affect in any manner or having as their intention to materially adversely affect in any manner the conduct or the business of the Company Entities and Persons. Notwithstanding the foregoing, comments made to Company Entities and Persons by you during the course of performing your duties hereunder shall not be deemed to be disparaging if made in good faith and in the best interest of the Company. Notwithstanding anything in this section to the contrary, nothing in this section shall prevent any person from (i) responding publicly to incorrect disparaging public statements to the extent reasonably necessary to correct or refute such public statement or (ii) making any truthful statement to the extent necessary with respect to any litigation or arbitration involving any agreement between or among the parties or required by law or by any court, arbitrator or administrative or legislative body (including any committee thereof) with apparent or actual jurisdiction to order such person to disclose or make accessible such information.

 

At-will Employment

 

Your employment with the Company will be for no specific period of time. Rather, your employment will be at-will, meaning that you or the Company may terminate the employment relationship at any time, with or without cause, and with or without notice and for any reason or no particular reason. Although your compensation and benefits may change from time to time, the at-will nature of your employment may only be changed by an express written agreement signed by an authorized officer of the Company.

 

Severance

 

If your employment with the Company is involuntarily terminated for reasons other than Cause or a breach by you of the terms and conditions of this letter (including, but not limited to, a breach of any of the representations contained herein), you shall be entitled to continue to receive your Base Salary (“Severance”) through the three-month anniversary of the effective date of termination if the termination occurs prior to the one-year anniversary of the Start Date, and through the six-month anniversary of the effective date of termination if the termination occurs after the one-year anniversary of the Start Date (the “Severance Period”), subject to your execution, and non-revocation, of a release of claims in a form provided by the Company (“General Release”) and the General Release has become effective, and only so long as you have not revoked or breached the provisions of the General Release or materially breached the provisions of this Offer Letter or the Company’s standard Employee Invention and Proprietary Information Agreement executed between you and the Company, and you do not apply for unemployment compensation chargeable to the Company or any subsidiary of the Company during the Severance Period. Subject to the following section, the Severance shall be paid in accordance with the Company’s regular payroll practices during the Severance Period.

 

11th Floor, Ten Grand Street, Brooklyn, NY 11249

www.healingcompany.com

      

 
5

 

 

 

Section 409A

 

This offer letter is intended to comply with Section 409A of the Internal Revenue Code (“Section 409A”) or an exemption thereunder and shall be construed and administered in accordance with Section 409A. Notwithstanding any other provision of this offer letter, payments provided under this offer letter may only be made upon an event and in a manner that complies with Section 409A or an applicable exemption. Any payments under this offer letter that may be excluded from Section 409A either as separation pay due to an involuntary separation from service or as a short-term deferral shall be excluded from Section 409A to the maximum extent possible. For purposes of Section 409A, each installment payment provided under this offer letter shall be treated as a separate payment. Any payments to be made under this offer letter upon a termination of employment shall only be made upon a “separation from service” under Section 409A. Notwithstanding the foregoing, the Company makes no representations that the payments and benefits provided under this offer letter comply with Section 409A and in no event shall the Company be liable for all or any portion of any taxes, penalties, interest or other expenses that may be incurred by you on account of non-compliance with Section 409A.

 

Notwithstanding any other provision of this offer letter, if any payment or benefit provided to you in connection with termination of employment is determined to constitute “nonqualified deferred compensation” within the meaning of Section 409A and you are determined to be a “specified employee” as defined in Section 409A(a)(2)(b)(i), then such payment or benefit shall not be paid until the first payroll date to occur following the six-month anniversary of your termination date (the “Specified Employee Payment Date”) or, if earlier, on the date of your death. The aggregate of any payments that would otherwise have been paid before the Specified Employee Payment Date shall be paid to you in a lump sum on the Specified Employee Payment Date and thereafter, any remaining payments shall be paid without delay in accordance with their original schedule.

 

Clawback

 

Any amounts payable hereunder are subject to any policy (whether currently in existence or later adopted) established by the Company providing for clawback or recovery of amounts that were paid to you. The Company will make any determination for clawback or recovery in its sole discretion and in accordance with any applicable law or regulation.

 

Governing Law

 

This offer letter shall be governed by the laws of Nevada, without regard to conflict of law principles.

 

11th Floor, Ten Grand Street, Brooklyn, NY 11249

www.healingcompany.com

     

 
6

 

 

 

 

Contingent Offer

 

This offer is contingent upon:

 

Verification of your right to work in the United States, as demonstrated by your completion of an I-9 form upon hire and your submission of acceptable documentation (as noted on the I-9 form) verifying your identity and work authorization within three days of your Start Date. For your

convenience, a copy of the I-9 Form’s List of Acceptable Documents is enclosed for your review. Satisfactory completion of reference checks.

 

Your execution of the Company’s enclosed Employee Information and Proprietary Inventions Agreement.

 

This offer will be withdrawn if any of the above conditions are not satisfied.

 

Representations

 

By accepting this offer, you represent that you are able to accept this job and carry out the work that it would involve without breaching any legal restrictions on your activities, such as non-competition, non-solicitation or other work-related restrictions imposed by a current or former employer. You also represent that you will inform the Company about any such restrictions and provide the Company with as much information about them as possible, including any agreements between you and your current or former employer describing such restrictions on your activities. You further confirm that you will not remove or take any documents or proprietary data or materials of any kind, electronic or otherwise, with you from your current or former employer to the Company without written authorization from your current or former employer, nor will you use or disclose any such confidential information during the course and scope of your employment with the Company. If you have any questions about the ownership of particular documents or other information, you should discuss such questions with your former employer before removing or copying the documents or information.

 

We are excited at the prospect of you joining our team. If you have any questions about the above details, please call me immediately. If you wish to accept this position, please sign below and return this letter to me within five (5) business days. This offer is open for you to accept until June 6, 2022, at which time it will be deemed to be withdrawn.

 

I look forward to hearing from you.

 

Yours sincerely,

 

 

Simon Belsham, CEO

 

 

On behalf of The Healing Company, Inc.

 

6/2/2022

 

 

 

Signed

 

 

 

 

11th Floor, Ten Grand Street, Brooklyn, NY 11249

www.healingcompany.com

        

 
7

 

 

 

Acceptance of Offer

 

I have read and understood and I accept all the terms of the offer of employment as set forth in the foregoing letter. I have not relied on any agreements or representations, express or implied, that are not set forth expressly in the foregoing letter, and this letter supersedes all prior and contemporaneous understandings, agreements, representations and warranties, both written and oral, with respect to the subject matter of this letter.

 

Amit Kapur
 

 

Signed

 

6/2/2022

 

 

 

Date

 

 

 

 

11th Floor, Ten Grand Street, Brooklyn, NY 11249

www.healingcompany.com

      

 
8

 

 EX-101.SCH 3 thcc-20220606.xsd XBRL TAXONOMY EXTENSION SCHEMA 000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 thcc-20220606_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Entity Registrant Name Entity Central Index Key Document Type Amendment Flag Entity Emerging Growth Company Document Period End Date Entity Incorporation State Country Code Entity Tax Identification Number Written Communications Soliciting Material Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Entity File Number Entity Address Address Line 1 Entity Address Address Line 2 Entity Address City Or Town Entity Address State Or Province Entity Address Postal Zip Code City Area Code Local Phone Number EX-101.CAL 5 thcc-20220606_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.PRE 6 thcc-20220606_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE EX-101.DEF 7 thcc-20220606_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE GRAPHIC 8 thcc_101img21.jpg begin 644 thcc_101img21.jpg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end GRAPHIC 9 thcc_101img22.jpg begin 644 thcc_101img22.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# 4$! 0$ P4$! 0&!04&" T(" <' M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_ MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @("#_P 1" P 'X# 2( A$! Q$!_\0 M'P 04! 0$! 0$ $" P0%!@<("0H+_\0 M1 @$# P($ P4% M! 0 %] 0(# 01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#Z/OO%]_-K M-QHWA70_[:N[1@EU<27 M[6U8C.QI,,6?&"553C(SBI/[0^)Q_YEOP[_ .#6 M;_XQ5?X7K_Q;72KIOFGO%>\G<]7EDD9W8^IR?Y5WOX5Y MY=XOUCX@6'@/5;RXL[32YHS;^5<:5.]W,@:XC60[&A XC+G.#]*YNU\?^-M+ M9+>WTZZU[39+^9-/O[RSD6;4(0T"K$/+10CYDF(D=0I6+.#RP]VHJ&[N]K&J M5E:YXK-\4O%5KI=Q?W/AUZFA/FX(#X6)7W+A?FQGO1%\5/'T MRW4A\#I"(M)BO!')',7#O'"S2X .^-6DD!08?]T<$G@>PV>D:7I]Q<7&GZ7: M62&%8VF;DY8@98\GKZFM6@#Q";Q=XTA^'NDZZ;[9=2^([B&:X?3IFA M^QAKC83$J^8(\+'@\-TRW))T='^(7BR^U633=1T:UT9[>QM]0N'FCEE$*3B$ M11%5PWF;_M*G(&!&I(Y->O5F0V-G;7ESZ;' ][:_UK8\4:5I.N>%M3T?7$C.F7-NZ7/F-L"IC);=_"1C(; ML1GM53_B2]694OX6P\0_#_5; MAM3U.#1'O=+U: _-J%LRM&C.!]V8-@$CALAACD#Q:U;QU<)H.J>'+?4M3T?1 MM.\.:LB6;LYO&55MV@4 XS\UP9/38-W2I-3ZVO+RUL+.:\OKJ*UMH5+R33.$ M2-1U+,> /-&E\1>$/MEW9>//$F MGZ;/).NY)K>&*R.^8GLQ*)"3Q^\D]J /JVN-^('C2Q\ >$CXAU"SENX5N(K? MRHF 8EVVC&>OT[UE>!_B)I/B:UT/3;>^.H:Q-IB75\(5S]CGV:2Q!O,C4_:?)489H0_[M2*-@ZL74#9,Y4(BYW?,6^ZI-<)I&I:'IO[)2>"['4GUS7'TN:>Z ML;-#+-;,9#+.LR]8@A+*=^,D<9)Q0![EI>K6OA7PAX3L/%6N*FHW<=KIR2W4 MA,EW=M&!CU9F8$Y_.JGPE=;[P9?:]U?6M9U"]8GJ5^TO''^4<<8'L!7(^-/% MOA6^UG0_&VBZA:ZM/X9N5@CA 62*^%WY:O%;M_%<(OEN-F#/%U MGX=O_A_H^K7TFEZ1X9M;^RU:YDD,=NNHG?M@F)(&_9%,X!SRZ=V% 'U)17R? MXJ\:7'C#XBZ9XFL;S5K32O#.N67F:>WF0-!8KL:YO;B#[V'-Q"$W#_5QR''W ML%C)\5-6\:R^(/#]KJT%J-9M#*T;G R5/S8&1GFG M^3\6O^@AX4_\!+G_ ..U_:1X;DLIHC=X59_W! ' M/^L8"4>9DX]1WFUM+FR=U<[V?2],NI5EN--MII5F6X5Y(58B11A7!(^\!P#U M%6/L\ O&NO*3[04$9EVC=M!R%SUQDDX]Z\PB\)ZK=16]PVGW5H;6*_GM ]Q^ M^CR2+6W8ASP!([XY (09XQ5:Z\&^)M/T[P[#8IYIB4R3I9J8@+G,/EM+NF)P M LP+J2?FX'/*&>N1PPQ,[1Q(C2'M&UPB^:?-CDRX61V* # M"A8\#(.-H!Z;#HNDV\-M%#IMG$EHYDMT2!5$+G.60 ?*3DY(]35J:SL[B,K< MVL4J%Q(5= 06&"&Y[C Y]J\BU7P_XWNMYF5KA8IEJ:?>>3R&Y/ M!(!M);V\4\L\<*)+-CS'50&? P,GO@5=HHH H6\$=OF&&-(U+,Y"*%!8G)/' + GRAPHIC 10 thcc_101img23.jpg begin 644 thcc_101img23.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# 4$! 0$ P4$! 0&!04&" T(" <' M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_ MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @("#_P 1" P &,# 2( A$! Q$!_\0 M'P 04! 0$! 0$ $" P0%!@<("0H+_\0 M1 @$# P($ P4% M! 0 %] 0(# 01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#Z2OO%VH3: MS<:/X4T'^V;JS8)=W$MP+>VMF(SL,F&+/C!*JIQD9(I?[0^)Q_YEOP[_ .#6 M;_XQ5?X7JO\ PK;2;H_-/>J]Y.YZO+([.['U.3_*N]_"KDXQ;C9.QA!2E%2; MW/,/%FK^.K'P)J=Y>6MII,LUC5*RM+;70Y-2G\.J\GF7$36\=A=[K65;>62*!R5P[F1$0LGR_-VR,Y]WXR\>6OB? M7XA)J-[$(S)#!!:-&MI^\@"JP:'/1Y-KK)()!G*KMX]I?6-/4F&*8W$H'W($ M,A_\=! I3J5Y(0L&EOD_\]ID3^1)_2@H\>L_BMXSU:_N-.TS2-,-V)HE*M!< M,+(-]KRDN"-[+]F0;EPI,G':EM_BGXZN3?2?\(>EI%#:6LX,\4[-")1;[YF5 M1EXU\Z4E5PW[D^^WU.RTJ;39;A]+TG1],-R_F3&WC.96_O-M5=QY/)K1-OK# M==2MT_W+4_U.S^-/'-E\-O"_B S%K^?4K];PSZ?,T:1>:/;Z0VG?96NS*DDI7[2T1AB 4_?"&97)X5E M4\*:]&%OJR\C5(7]GMN/T85#IMG#9K.RV-M;75S(9;@VR;1,_3>QP"20!RL>+O$UG8VEK"T\_P#9UL8TA102Q+R%V; '4!?I5+PKH=CJOAN35-:T M]IY=;W7#1WV7DB@=0(XVW'[+Q5XF^)-%GTG5K<36L MPY!ZJ1R&'H0:S+/P5I,=E!#<>>)8UPS6EW<6Z$^H19,+]* $N;=VB:6P\-PV M>%+&6ZNA;*.^3Y6X_GBO,]/\4>)O$*WNIZ3JD4'A^P^::Y2[,H(9SQ7*Z_\(_#. MH1Z##I-E%I$6F7T4\@MRR&6!8"0>![BNOKY]\#Z-\2-)TZXT70=:N)8=-O)[=;2_:$6\,6\F, M!]AF^Z<<[NG7M7;>$KKX@7FL:KI?C!9+*2W8&UNK"W3[+,F!GYY 69LL>-J\ M*3WQ0!Z915:W2:.W1)YO.E PTFW;N]\#I5F@ HHHH X3X7L?^%9Z-;R#;+:Q MM:RH>J21NR.I]P5-=Q]>E<+>>%=6L=9NM8\&ZQ%IDMZ_FW=E=P&>UN),8\S: M&5HW.!DJ<-@9&>:=Y/Q:_P"@AX3_ / 2Y_\ CM5*TI.2>YA!N$5%IZ'=4E>: MZYI_C^^\)ZA;ZLVE7CM+:M'%I<$JNRK<1M)N#RC<-@;Y0RYY&>:Q]-T7Q#%! M:?VUH.I7T2I(MA%:WGD?9)/M,CJ[CS28P8VB ^:38L97O@JUGN:IW5['LE%> M$R^&_&@+_P!HV-U>@ZAYMRY7SEE;9S:2_2\!40):Q+/'N\SYF8K( ,??8-GC=2*/9J*\:L=%\;-9:,U MAIMSI]BFL17ESITU^R20*&C&S<2_FQA0[-\PWR$G&.#1T7PSXZ_L6XT>.QFM M5OX+6WN9YYFM]C(9&F;*RR,S,-J>8H7.X<<$@ [KPUINI67CGQE M0#U*BO#;KP_\1I(G^W1SR79U.2[62UO3+&SF @,8_*B#+( V&* ?=8MD]C MX7BU"QU+7;Z;1=4LTGFVQ6TTGG;PID/G%C( XML 11 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Cover
Jun. 06, 2022
Cover [Abstract]  
Entity Registrant Name THE HEALING COMPANY INC.
Entity Central Index Key 0001441082
Document Type 8-K
Amendment Flag false
Entity Emerging Growth Company false
Document Period End Date Jun. 06, 2022
Entity Incorporation State Country Code NV
Entity Tax Identification Number 26-2862618
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Entity File Number 333-152805
Entity Address Address Line 1 11th Floor
Entity Address Address Line 2 Ten Grand Street
Entity Address City Or Town Brooklyn
Entity Address State Or Province NY
Entity Address Postal Zip Code 11249
City Area Code 866
Local Phone Number 241-0670
XML 12 thcc_8k_htm.xml IDEA: XBRL DOCUMENT 0001441082 2022-06-06 2022-06-06 iso4217:USD shares iso4217:USD shares 0001441082 false 8-K 2022-06-06 THE HEALING COMPANY INC. NV 333-152805 26-2862618 11th Floor Ten Grand Street Brooklyn NY 11249 866 241-0670 false false false false false EXCEL 13 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 15 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 16 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 1 20 1 false 0 0 false 3 false false R1.htm 000001 - Document - Cover Sheet http://thcc.com/role/Cover Cover Cover 1 false false All Reports Book All Reports thcc_8k.htm thcc-20220606.xsd thcc-20220606_cal.xml thcc-20220606_def.xml thcc-20220606_lab.xml thcc-20220606_pre.xml thcc_101.htm http://xbrl.sec.gov/dei/2021q4 true true JSON 18 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "thcc_8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "calculationLink": { "local": [ "thcc-20220606_cal.xml" ] }, "definitionLink": { "local": [ "thcc-20220606_def.xml" ] }, "inline": { "local": [ "thcc_8k.htm" ] }, "labelLink": { "local": [ "thcc-20220606_lab.xml" ] }, "presentationLink": { "local": [ "thcc-20220606_pre.xml" ] }, "schema": { "local": [ "thcc-20220606.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/currency/2021/currency-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd", "https://xbrl.sec.gov/exch/2021/exch-2021.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd", "https://xbrl.sec.gov/sic/2021/sic-2021.xsd", "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" ] } }, "elementCount": 21, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021q4": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 20, "memberCustom": 0, "memberStandard": 0, "nsprefix": "thcc", "nsuri": "http://thcc.com/20220606", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "thcc_8k.htm", "contextRef": "From2022-06-06to2022-06-06", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000001 - Document - Cover", "role": "http://thcc.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "thcc_8k.htm", "contextRef": "From2022-06-06to2022-06-06", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thcc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thcc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thcc.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thcc.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line 1" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thcc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address Address Line 2" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thcc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thcc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thcc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thcc.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thcc.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thcc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thcc.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thcc.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thcc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thcc.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thcc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thcc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thcc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thcc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thcc.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r4": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 19 0001477932-22-004373-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001477932-22-004373-xbrl.zip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end